News & Stories

Meet Dr. Melody CHUNG Jin-Teng, a HKUST-nurtured female researcher and entrepreneur whose delivery technology start-up Allegrow Biotech Ltd. (“Allegrow”) is ensuring needy patients can easily access affordable top quality cell therapeutics.

People who suffer from diabetic retinopathy and macular degeneration would usually be treated with intravitreal eye injections — a procedure to deliver drugs directly to the eye using a thin, tiny needle. This invasive treatment involves a certain degree of risk and the scary-looking procedure is surely not for the fainted heart. Langston SUEN and his fellow researchers at HKUST explored an alternative method of non-invasive drug delivery using ultrasound as part of his PhD studies at the University. Now he is working with pharmaceuticals to bring the technology to market.